Journal of Clinical Oncology

Trastuzumab: No negative impact on cardiac function

Long-term follow-up results of the NRG Oncology trial NSABP B-31 have shown that the addition of trastuzumab to adjuvant chemotherapy does not negatively affect cardiac function in women with node-positive, human epidermal ...

Jan 03, 2018
popularity1 comments 0